GSE199862 Chk1 inhibition 0 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE199862_Chk1 inhibition_0_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE199862_Chk1 inhibition_0_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE199862_Chk1 inhibition_0_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE199862_Chk1 inhibition_0_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

tripartite motif containing 16 like (pseudogene)

Gene

POU class 3 homeobox 3

Gene

PAX8 antisense RNA 1

Gene

HOXA10 antisense RNA

Gene

long intergenic non-protein coding RNA 1564

Gene

long intergenic non-protein coding RNA 3209

Gene

MAPK8IP3 antisense RNA 1

Gene

ETV5 antisense RNA 1

Gene

uncharacterized LOC105371062

Gene

RNF14 pseudogene 3

  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    POU class 3 homeobox 3


  • Gene

    PAX8 antisense RNA 1


  • Gene

    HOXA10 antisense RNA


  • Gene

    long intergenic non-protein coding RNA 1564


  • Gene

    long intergenic non-protein coding RNA 3209


  • Gene

    MAPK8IP3 antisense RNA 1


  • Gene

    ETV5 antisense RNA 1


  • Gene

    uncharacterized LOC105371062


  • Gene

    RNF14 pseudogene 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.